All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study
Previous studies have demonstrated the immunosuppressive effects of both all-trans retinoic acid (ATRA) and mesenchymal stem cells (MSCs). The present study aimed to assess the immunoregulatory effects of ATRA on MSCs in the treatment of ankylosing spondylitis (AS). Bone marrow-derived MSCs from hea...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2015/484528 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832560518129254400 |
---|---|
author | Deng Li Peng Wang Yuxi Li Zhongyu Xie Le Wang Hongjun Su Wen Deng Yanfeng Wu Huiyong Shen |
author_facet | Deng Li Peng Wang Yuxi Li Zhongyu Xie Le Wang Hongjun Su Wen Deng Yanfeng Wu Huiyong Shen |
author_sort | Deng Li |
collection | DOAJ |
description | Previous studies have demonstrated the immunosuppressive effects of both all-trans retinoic acid (ATRA) and mesenchymal stem cells (MSCs). The present study aimed to assess the immunoregulatory effects of ATRA on MSCs in the treatment of ankylosing spondylitis (AS). Bone marrow-derived MSCs from healthy donors were pretreated with ATRA and cocultured with CD3/28-activated peripheral blood mononuclear cells (PBMCs) derived from AS patients. Frequencies of Th17 and regulatory T (Treg) cells were analyzed using flow cytometry. The secretion and the mRNA level of key cytokines were measured with cytometric bead array and quantitative real-time PCR, respectively. ATRA pretreatment increased interleukin-6 (IL-6) secretion of MSCs. Th17 and Treg subset populations were increased and reduced by ATRA-pretreated MSCs, respectively. ATRA-pretreated MSCs significantly decreased not only the vital pathogenic cytokine in AS, tumor necrosis factor-α (TNF-α), but also AS-boosting factors interleukin-17 (IL-17A) and interferon-γ (IFN-γ). These results indicated that IL-6 may be a potential protective factor in AS and highlighted the promising role of ATRA in improving the efficacy of MSC-based treatment of AS. |
format | Article |
id | doaj-art-51fc421ccd6a4824a4c5a2647eb082b9 |
institution | Kabale University |
issn | 1687-966X 1687-9678 |
language | English |
publishDate | 2015-01-01 |
publisher | Wiley |
record_format | Article |
series | Stem Cells International |
spelling | doaj-art-51fc421ccd6a4824a4c5a2647eb082b92025-02-03T01:27:16ZengWileyStem Cells International1687-966X1687-96782015-01-01201510.1155/2015/484528484528All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro StudyDeng Li0Peng Wang1Yuxi Li2Zhongyu Xie3Le Wang4Hongjun Su5Wen Deng6Yanfeng Wu7Huiyong Shen8Department of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaCenter for Biotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaCenter for Biotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaCenter for Biotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaPrevious studies have demonstrated the immunosuppressive effects of both all-trans retinoic acid (ATRA) and mesenchymal stem cells (MSCs). The present study aimed to assess the immunoregulatory effects of ATRA on MSCs in the treatment of ankylosing spondylitis (AS). Bone marrow-derived MSCs from healthy donors were pretreated with ATRA and cocultured with CD3/28-activated peripheral blood mononuclear cells (PBMCs) derived from AS patients. Frequencies of Th17 and regulatory T (Treg) cells were analyzed using flow cytometry. The secretion and the mRNA level of key cytokines were measured with cytometric bead array and quantitative real-time PCR, respectively. ATRA pretreatment increased interleukin-6 (IL-6) secretion of MSCs. Th17 and Treg subset populations were increased and reduced by ATRA-pretreated MSCs, respectively. ATRA-pretreated MSCs significantly decreased not only the vital pathogenic cytokine in AS, tumor necrosis factor-α (TNF-α), but also AS-boosting factors interleukin-17 (IL-17A) and interferon-γ (IFN-γ). These results indicated that IL-6 may be a potential protective factor in AS and highlighted the promising role of ATRA in improving the efficacy of MSC-based treatment of AS.http://dx.doi.org/10.1155/2015/484528 |
spellingShingle | Deng Li Peng Wang Yuxi Li Zhongyu Xie Le Wang Hongjun Su Wen Deng Yanfeng Wu Huiyong Shen All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study Stem Cells International |
title | All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study |
title_full | All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study |
title_fullStr | All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study |
title_full_unstemmed | All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study |
title_short | All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study |
title_sort | all trans retinoic acid improves the effects of bone marrow derived mesenchymal stem cells on the treatment of ankylosing spondylitis an in vitro study |
url | http://dx.doi.org/10.1155/2015/484528 |
work_keys_str_mv | AT dengli alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy AT pengwang alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy AT yuxili alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy AT zhongyuxie alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy AT lewang alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy AT hongjunsu alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy AT wendeng alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy AT yanfengwu alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy AT huiyongshen alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy |